Critical Illness After Hematopoietic Cell Transplantation

This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.

NCT Number	NCT07328724
Lead Sponsor	Peking University People's Hospital Collaborators: Chinese Academy of Medical Sciences, Xinqiao hospital of the third military medical university, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Harbin Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions	Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Enrollment	4,000 participants
Start Date	2026-01-01
Primary Completion	2036-06-30 (estimated)
Study Completion	2036-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-09